Literature DB >> 11721176

Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.

C Egawa1, Y Miyoshi, K Iwao, E Shiba, S Noguchi.   

Abstract

OBJECTIVES: We have conducted a quantitative analysis of estrogen receptor-alpha (ER-alpha) and -beta (ER-beta) mRNA expression in normal thyroid and tumor tissues.
METHODS: Normal thyroid tissues (n = 10) and tumor tissues [(follicular adenoma (n = 14), follicular carcinoma (n = 8), papillary carcinoma (n = 14), anaplastic carcinoma (n = 3) and medullary carcinoma (n = 6)] were obtained at surgery from 45 female patients. ER-alpha and ER-beta mRNA expression has been studied by a quantitative polymerase chain reaction.
RESULTS: ER-alpha mRNA levels in the normal thyroid were not significantly different from those in follicular adenomas, papillary carcinomas and medullary carcinomas but were marginally (p = 0.08) higher than those in follicular and anaplastic carcinomas. ER-beta mRNA levels in the normal thyroid tissues were not significantly different from those in any other tumor tissues. ER-beta to ER-alpha mRNA ratios were significantly (p < 0.05) higher in the normal thyroid tissues than in follicular adenomas. Proportions of ER-beta mRNA variants (ER-beta 1, 2, 5, and 5') did not significantly differ among the normal and tumor tissues.
CONCLUSIONS: A downregulation of ER-alpha mRNA in follicular and anaplastic carcinomas seems to suggest that estrogens are unlikely to play an important role in the carcinogenesis and progression of these carcinomas. On the other hand, a significant decrease in ER-beta to ER-alpha mRNA ratios in follicular adenomas suggests a possible involvement of estrogens in the pathogenesis of this disease since the same phenomenon has been reported on estrogen-dependent breast cancers. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721176     DOI: 10.1159/000055336

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Pregnancy and multinodular goiter.

Authors:  G Papi; C Carapazzi
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.

Authors:  R L Babu; M Naveen Kumar; Rajeshwari H Patil; K S Devaraju; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

3.  Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma.

Authors:  Claire Bléchet; Pierre Lecomte; Loïc De Calan; Patrice Beutter; Serge Guyétant
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

4.  Role of estrogen in thyroid function and growth regulation.

Authors:  Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-05-04

Review 5.  Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.

Authors:  Ana Božović; Vesna Mandušić; Lidija Todorović; Milena Krajnović
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

6.  Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.

Authors:  Shucai Yang; Zhongqin Gong; Zhimin Liu; Minghui Wei; Lingbin Xue; Alexander C Vlantis; Yang Zhang; Jason Yk Chan; C Andrew van Hasselt; Xianhai Zeng; Shuqi Qiu; Nelson Tang; Jing Du; Wei Wei; Michael Cf Tong; George G Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-07       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.